T. Rowe Price Associates’s Rapport Therapeutics RAPP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$17.3M	Buy	1,525,519 +452,311	+42%	+$5.14M	﹤0.01%	986
2025 Q1	$10.8M	Sell	1,073,208 -70,176	-6%	-$704K	﹤0.01%	1100
2024 Q4	$20.3M	Buy	1,143,384 +95,976	+9%	+$1.7M	﹤0.01%	991
2024 Q3	$21.5M	Sell	1,047,408 -313,197	-23%	-$6.41M	﹤0.01%	978
2024 Q2	$31.6M	Buy	+1,360,605	New	+$31.6M	﹤0.01%	845